Boditech Med Inc. (206640.KQ)

KRW 17340.0

(0.29%)

Operating Expenses Summary of Boditech Med Inc.

Boditech Med Inc.'s latest annual operating expenses in 2023 was 47.05 Billion KRW , up 13.25% from previous year.
Boditech Med Inc.'s latest quarterly operating expenses in 2024 Q2 was 12.42 Billion KRW , down -13.43% from previous quarter.
Boditech Med Inc. reported a annual operating expenses of 44.08 Billion KRW in annual operating expenses 2022, down -2.9% from previous year.
Boditech Med Inc. reported a annual operating expenses of 45.4 Billion KRW in annual operating expenses 2021, up 50.78% from previous year.
Boditech Med Inc. reported a quarterly operating expenses of 12.42 Billion KRW for 2024 Q2, down -13.43% from previous quarter.
Boditech Med Inc. reported a quarterly operating expenses of 12.43 Billion KRW for 2023 Q2, up 5.47% from previous quarter.

Annual Operating Expenses Chart of Boditech Med Inc. (2023 - 2015)

Historical Annual Operating Expenses of Boditech Med Inc. (2023 - 2015)

Year	Operating Expenses	Operating Expenses Growth
2023	47.05 Billion KRW	13.25%
2022	44.08 Billion KRW	-2.9%
2021	45.4 Billion KRW	50.78%
2020	30.11 Billion KRW	13.2%
2019	26.6 Billion KRW	4.12%
2018	25.54 Billion KRW	-1.05%
2017	25.81 Billion KRW	22.38%
2016	21.09 Billion KRW	53.35%
2015	13.75 Billion KRW	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	13.31 Billion KRW	-6.88%
2024 Q2	12.42 Billion KRW	-13.43%
2023 Q2	12.43 Billion KRW	5.47%
2023 FY	49.92 Billion KRW	13.25%
2023 Q3	11.39 Billion KRW	-8.35%
2023 Q1	11.79 Billion KRW	12.77%
2023 Q4	14.29 Billion KRW	25.42%
2022 FY	44.08 Billion KRW	-2.9%
2022 Q1	12.67 Billion KRW	-19.94%
2022 Q2	10.35 Billion KRW	-18.32%
2022 Q3	10.65 Billion KRW	2.93%
2022 Q4	10.45 Billion KRW	-1.86%
2021 FY	45.4 Billion KRW	50.78%
2021 Q3	9.87 Billion KRW	1.99%
2021 Q1	9.26 Billion KRW	-38.26%
2021 Q2	9.67 Billion KRW	4.51%
2021 Q4	15.83 Billion KRW	60.37%
2020 Q2	7.6 Billion KRW	26.7%
2020 FY	30.11 Billion KRW	13.2%
2020 Q4	15 Billion KRW	81.28%
2020 Q3	8.27 Billion KRW	8.78%
2020 Q1	6 Billion KRW	-14.53%
2019 Q4	7.02 Billion KRW	17.68%
2019 FY	26.6 Billion KRW	4.12%
2019 Q1	6.61 Billion KRW	-51.83%
2019 Q2	6.51 Billion KRW	-1.41%
2019 Q3	5.97 Billion KRW	-8.38%
2018 FY	25.54 Billion KRW	-1.05%
2018 Q4	13.72 Billion KRW	89.64%
2018 Q2	5.86 Billion KRW	-7.08%
2018 Q3	7.23 Billion KRW	23.31%
2018 Q1	6.31 Billion KRW	-53.85%
2017 Q2	5.81 Billion KRW	0.63%
2017 Q1	5.77 Billion KRW	5.87%
2017 FY	25.81 Billion KRW	22.38%
2017 Q4	13.68 Billion KRW	125.12%
2017 Q3	6.07 Billion KRW	4.59%
2016 Q2	6.1 Billion KRW	90.38%
2016 Q4	5.45 Billion KRW	-5.66%
2016 Q1	3.2 Billion KRW	-67.7%
2016 Q3	5.78 Billion KRW	-5.29%
2016 FY	21.09 Billion KRW	53.35%
2015 Q4	9.93 Billion KRW	-9.07%
2015 FY	13.75 Billion KRW	0.0%
2015 Q3	10.92 Billion KRW	184.06%
2015 Q1	3.14 Billion KRW	0.0%
2015 Q2	3.84 Billion KRW	22.13%

Peer Operating Expenses Comparison of Boditech Med Inc.

Name	Operating Expenses	Operating Expenses Difference
HLB Pharmaceutical Co., Ltd	102.52 Billion KRW	54.108%
CMG Pharmaceutical Co., Ltd.	37.86 Billion KRW	-24.258%
Celltrion Pharm, Inc.	80.93 Billion KRW	41.865%
Huons Global Co., Ltd.	294.87 Billion KRW	84.044%
DongKook Pharmaceutical Co., Ltd.	338.16 Billion KRW	86.086%
Enzychem Lifesciences Corporation	18.7 Billion KRW	-151.557%
Humedix Co., Ltd.	33.04 Billion KRW	-42.394%
EuBiologics Co., Ltd.	24.95 Billion KRW	-88.51%
FutureChem Co.,Ltd	9.16 Billion KRW	-413.323%
Huons Co., Ltd.	226.14 Billion KRW	79.194%
BNC Korea Co., Ltd.	25.19 Billion KRW	-86.722%
AptaBio Therapeutics Inc.	16.45 Billion KRW	-185.995%